Ovulography and the Ovulograph

The concept of ovulographyTM is that:

a) the menstrual cyclic profile captured by the OvulonaTM is diagnostically useful for the healthcare provider, and  

b) correlating the menstrual cyclic profile data with symptoms or other observables in the course of managing a female patient is of fundamental importance to the healthcare provider.

This is demonstrated on an example of differential diagnosis, PMS/PMDD vs. clinical depression:

https://biozhena.files.wordpress.com/2017/02/ovulograph-ovulography-slides-dec-2016-1.pps

View these slides (they take a few moments to open) as a hint on how the bioZhena ovulographicTM technology “…could shed light on premenstrual dysphoric disorder (PMDD), which affects one in 12 women in the days leading up to her period. Symptoms include severe mood swings and anxiety.

The researchers contend [that] if women are particularly receptive in certain phases of their cycle to making changes in their behavior, this could be a good time for PMDD patients to undergo therapy. However, they first need to find out which monthly rhythm the brain of a healthy woman follows to reveal the differences in people affected by PMDD

(cited from “Menstrual Cycle Helps Female Brain Grow: Estrogen Levels Boost Volume Of Hippocampus During Ovulation” at http://www.medicaldaily.com/menstrual-cycle-helps-female-brain-grow-estrogen-levels-boost-volume-401295).

It is the idea that “they first need to find out which monthly rhythm the brain of a healthy woman follows” where ovulography comes in and provides for a measurable comparison between the healthy and the ill. A routinely measurable comparison directly reporting the “monthly rhythm”, and far less demanding than the currently available methods. Thereby significantly improving access to care for the many PMS/PMDD sufferers. Improving the quality of care is to be expected.

As the Medical Daily article indicates, “Barth and her team of researchers observed 30 women and measured the levels of estrogen in their blood across two full menstrual cycles. The women also underwent MRI scans, which the researchers used to measure the volume of the different regions within each woman’s brain.”

Our ovulographicTM technology brings significant advantages into the PMS/PMDD field. It provides the folliculogenesis and the symptometric data for the MRI brain scan research, and subsequently it provides a practical medical routine means for administering therapy based on individual patient’s monitoring in the comfort of their home.

Ovulographic Correlation of Folliculogenesis and Symptometric Data

For more about PMS and PMDD, go to https://biozhena.wordpress.com/2007/12/17/premenstrual-syndrome-pms-and-pmdd/ .

For more about the Ovulona sensor, go to https://biozhena.wordpress.com/the-ovulona/.

.

.

Advertisements

%d bloggers like this: